Table 1.
Patients with a visit between 1/1/2019–2/29/2020 | Patients with COVID-19 (03/01/2020–10/10/2020)b | ||||
---|---|---|---|---|---|
% patients with preexisting conditionsa by 2/29/2020 | No. patients | % patients without preexisting conditionsa by 10/10/2020 | |||
All patients | 61% | 7,532 | 33% | ||
Hispanic | 55% | 4,391 | 36% | ||
Non-Hispanic Asian | 44% | 244 | 51% | ||
Non-Hispanic Black | 60% | 1,474 | 28% | ||
Non-Hispanic Other | 68% | 72 | 21% | ||
Non-Hispanic White | 71% | 1,004 | 22% | ||
Unknown | 55% | 347 | 37% |
Preexisting conditions include HIV/AIDS; lupus; alcohol and drug abuse (excludes tobacco use); mental disorders (eg, depression, bipolar disorder); Alzheimer’s/dementia; multiple sclerosis; rheumatoid arthritis, fibromyalgia, and other inflammatory joint disease; muscular dystrophy; cancer other than skin; severe obesity; cerebral palsy; congestive heart failure; paraplegia and paralysis; coronary artery disease; Crohn’s disease and ulcerative colitis; Parkinson’s disease; chronic obstructive pulmonary disease, emphysema, and asthma; diabetes mellitus; pneumocystic pneumonia; epilepsy; hemophilia; sleep apnea; hepatitis; stroke; and kidney disease/renal failure. Preexisting conditions identified among patient with an in-person office visit between 1/1/2019–2/29/2020.
Patients with COVID-19 are those with a positive laboratory result in their EHR record or a COVID-19 diagnosis code.